Our most popular articles and videos for the week ended March 7.
Biotech rules and bonds disappoint for many Morningstar.com readers.
Fidelity's growth-leaning equity funds and more conservative bond funds made for a strong year for the fund firm, says Morningstar analyst Katie Reichart.
Funds that held up better than their peers in 2008 soon may not compare as favorably, as five-year returns move forward.
International opportunities, income, and M&A activity were on investors' minds in September.